Litcius/Paper detail

Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma

Li Xu, Yingcong Wang, Guanli Wang, Shushan Guo, Dandan Yu, Qilin Feng, Ke Hu, Gege Chen, Bo Li, Zhijian Xu, Xinyan Jia, Yumeng Lu, Hui Zhang, Xuejie Gao, Shuaikang Chang, Huaping Wang, Xiaosong Wu, Dongliang Song, Guang Yang, Huabin Zhu, Jinfeng Zhou, Fenghuang Zhan, Weiliang Zhu, Jumei Shi

2023Leukemia18 citationsDOI

Topics & Concepts

EZH2Cancer researchMultiple myelomaMedicineSignal transductionInternal medicineBiologyOncologyCell biologyGeneticsGeneHistoneGenetics and Neurodevelopmental DisordersHistone Deacetylase Inhibitors ResearchEpigenetics and DNA Methylation
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma | Litcius